Janssen counts with a broad innovation trajectory in the area of immunology. Our medications in this area are constituted of therapeutic resources of proven efficacy in a variety of chronic diseases such as: rheumatoid arthritis, inflammatory bowel disease (Crohn’s disease, ulcerative colitis), ankylosing spondylitis, psoriatic arthritis and psoriasis.